4-(4-Phenoxyphenyl)piperidine → 5-[4-(4-(4-Phenoxyphenyl)piperidin-1-yl)butyryl]-2,3,4,5-tetrahydro-1,5-benzoxazepine
반응식
Cl[CH2:2][CH2:3][CH2:4][C:5]([N:7]1[C:13]2[CH:14]=[CH:15][CH:16]=[CH:17][C:12]=2[O:11][CH2:10][CH2:9][CH2:8]1)=[O:6].[O:18]([C:25]1[CH:30]=[CH:29][C:28]([CH:31]2[CH2:36][CH2:35][NH:34][CH2:33][CH2:32]2)=[CH:27][CH:26]=1)[C:19]1[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=1>>[O:18]([C:25]1[CH:30]=[CH:29][C:28]([CH:31]2[CH2:36][CH2:35][N:34]([CH2:2][CH2:3][CH2:4][C:5]([N:7]3[C:13]4[CH:14]=[CH:15][CH:16]=[CH:17][C:12]=4[O:11][CH2:10][CH2:9][CH2:8]3)=[O:6])[CH2:33][CH2:32]2)=[CH:27][CH:26]=1)[C:19]1[CH:20]=[CH:21][CH:22]=[CH:23][CH:24]=1참가 물질
3
실험 절차
The compound (16) synthesized in Reference Example 16 and the compound (4) synthesized in Reference Example 4 were used to produce the above compound in the same way as Example 1.
후처리
- customto produce the above compound in the same way as Example 1
출처 및 근거
- ORD 기록
- ord-e1dcf3764cea4e59a631d89d7f2b7e7d